Thiotepa Riemser Umoja wa Ulaya - Kicheki - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastická činidla - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Zynteglo Umoja wa Ulaya - Kicheki - EMA (European Medicines Agency)

zynteglo

bluebird bio (netherlands) b.v. - autologní cd34+ buněk obohacený populace, která obsahuje krvetvorné kmenové buňky transduced s lentiglobin bb305 lentiviral vektor kódující beta--t87q-globin gene - beta-talasémie - other hematological agents - zynteglo je indikován pro léčbu pacientů od 12 let a starší s závislá na transfuzi β talasemie (tdt), kteří nemají β0/β0 genotyp, pro koho hematopoetických kmenových buněk (hsc) transplantaci je vhodné, ale lidský leukocytární antigen (hla)-uzavřeno související dárce hsc není k dispozici.

CYCLOPHOSPHAMIDE ACCORD 1000MG Prášek pro injekční/infuzní roztok Jamhuri ya Cheki - Kicheki - SUKL (Státní ústav pro kontrolu léčiv)

cyclophosphamide accord 1000mg prášek pro injekční/infuzní roztok

accord healthcare polska sp. z o.o., varšava polsko - 1619 cyklofosfamid - prášek pro injekční/infuzní roztok - 1000mg - cyklofosfamid

CYCLOPHOSPHAMIDE ACCORD 500MG Prášek pro injekční/infuzní roztok Jamhuri ya Cheki - Kicheki - SUKL (Státní ústav pro kontrolu léčiv)

cyclophosphamide accord 500mg prášek pro injekční/infuzní roztok

accord healthcare polska sp. z o.o., varšava polsko - 1619 cyklofosfamid - prášek pro injekční/infuzní roztok - 500mg - cyklofosfamid

Libmeldy Umoja wa Ulaya - Kicheki - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - další léky na nervový systém - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Phelinun Umoja wa Ulaya - Kicheki - EMA (European Medicines Agency)

phelinun

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastická činidla - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

ENTIZOL 250MG Tableta Jamhuri ya Cheki - Kicheki - SUKL (Státní ústav pro kontrolu léčiv)

entizol 250mg tableta

zaklady farmaceutyczne polpharma sa, starogard gdański array - 943 metronidazol - tableta - 250mg - metronidazol

METRONIDAZOLE POLPHARMA 5MG/ML Infuzní roztok Jamhuri ya Cheki - Kicheki - SUKL (Státní ústav pro kontrolu léčiv)

metronidazole polpharma 5mg/ml infuzní roztok

zaklady farmaceutyczne polpharma sa, starogard gdański array - 943 metronidazol - infuzní roztok - 5mg/ml - metronidazol

ALKERAN 2MG Potahovaná tableta Jamhuri ya Cheki - Kicheki - SUKL (Státní ústav pro kontrolu léčiv)

alkeran 2mg potahovaná tableta

aspen pharma trading limited, dublin array - 1571 melfalan - potahovaná tableta - 2mg - melfalan

ALKERAN 50MG Prášek a rozpouštědlo pro injekční/infuzní roztok Jamhuri ya Cheki - Kicheki - SUKL (Státní ústav pro kontrolu léčiv)

alkeran 50mg prášek a rozpouštědlo pro injekční/infuzní roztok

aspen pharma trading limited, dublin array - 1571 melfalan - prášek a rozpouštědlo pro injekční/infuzní roztok - 50mg - melfalan